Just wondering - what would be the main reason(s) why the FDA should not approve Zircaix?
I am a small cap investor from Germany. I do not know much about Telix, aside that they appear to do a great job looking at the shareprice. I stumbled upon Telix while researching a German company called Heidelberg Pharma from which Telix inlicensed the antibody used in Zircaix. Heidelberg Pharma is entiteld to receive royalties from Telix (20% of Zircaix product sales if I am not mistaken). They did a partial sale of there royalty stream for Zircaix and would receive USD 75m upon Zircaix FDA approval.
PR: Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million - Heidelberg Pharma AG (heidelberg-pharma.com)
Heidelberg Pharma trading at an Mcap of just EUR 120m, EV < 100m. The market appears to price in a high risk of Zircaix not receiving FDA approval.
Happy to hear your thoughts!
Disclosure: I hold a position in Heidelberg Pharma.
Just wondering - what would be the main reason(s) why the FDA...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.81 |
Change
-0.545(2.82%) |
Mkt cap ! $6.316B | |||
| Open | High | Low | Value | Volume |
| $18.92 | $19.21 | $18.75 | $11.13M | 586.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1080 | $18.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.81 | 410 | 8 |
View Market Depth
| Last trade - 13.42pm 02/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |